Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Are There Ongoing Clinical Trials for Cannabis and ME/CFS? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

With growing interest in alternative therapies, the question of whether there are clinical trials of cannabis for ME/CFS is becoming increasingly relevant. While research into ME/CFS remains underfunded compared to other chronic illnesses, several studies are now exploring the role of cannabis in managing symptoms. 

Is medical cannabis an option for me?

The State of Cannabis Clinical Research in ME/CFS 

Current clinical trials of cannabis for ME/CFS vary in design, with some focusing on symptom relief and others on understanding how cannabis interacts with the underlying mechanisms of the disease. A number of cannabis and ME/CFS studies are ongoing and aim to investigate pain reduction, sleep quality improvements, and mood regulation. 

Examples of Current and Planned Studies 

These research efforts are helping to shape the future of cannabis-based ME/CFS care. 

Symptom-Focused Trials 

Some ME/CFS and cannabis trial updates highlight studies designed to measure improvements in fatigue, cognitive clarity, and physical function following cannabis use. 

Mechanism-Based Research 

Other clinical research of cannabis and ME/CFS projects is examining how cannabinoids affect immune and neurological pathways linked to the condition. 

Comparative Effectiveness Studies 

Researchers are also exploring how cannabis compares to standard ME/CFS treatments in terms of both benefits and side effects. 

While the number of trials is still limited, ongoing research is an encouraging sign for patients seeking more options. As results emerge, they could help guide safer and more effective cannabis use in ME/CFS management. 

Visit providers like LeafEase for personalised consultations and lawful, medically guided pain management options. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Myalgic Encephalomyelitis (ME/CFS).

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories